Emerging Infectious Diseases
On behalf of 190 participating economies, the global COVAX initiative has secured access to nearly 2 billion COVID-19 vaccine candidates and plans to begin dispensing those doses early next year to protect vulnerable groups.
While most of the vaccine candidates involved are still under... Read More »
The Defense Advanced Research Projects Agency (DARPA) and the Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense (JPEO-CBRND) have earmarked $37.6 million for COVID-19 treatment development.
A research team representing scientists from The Wistar Institute,... Read More »
Thanks to an expansion of a partnership with the Biomedical Advanced Research and Development Authority (BARDA), Hologic, Inc. will accelerate the development of the Aptima SARS-CoV-2/Flu assay, dangling the promise of a test capable of differentiating between the pair.
Specifically, the test... Read More »
A Moderna, Inc. vaccine is on track to become the second COVID-19 vaccine approved for emergency use in the United States, following this week's positive endorsement from the Vaccines and Related Biological Products Advisory Committee (VRBPAC).
The VRBPAC, an advisory committee for the U.S. Food... Read More »
Researchers at Rensselaer Polytechnic Institute are looking to improve the manufacturing of rapidly deployed structures to address future shortages of medical care and quarantine facilities during a health crisis, like the current pandemic.
The stress that COVID-19 has placed on medical... Read More »
World Health Organization (WHO) personnel and officials representing Sanofi, one of the world’s leading pharmaceutical companies, said the entities are partnering to readdress neglected tropical diseases (NTDs).
“This decades-long collaboration exemplifies a successful public–private... Read More »
The U.S. Food and Drug Administration (FDA) issued an emergency use authorization (EUA) to Abbott this week for its BinaxNOW COVID-19 Ag Card Home Test, allowing for virtually guided use by anyone 15 years or older, with a prescription.
Healthcare providers will refer such patients to the... Read More »
Bavarian Nordic A/S secured $83 million in funding from the Biomedical Advanced Research and Development Authority (BARDA) this week, marking a second investment into its JYNNEOS smallpox vaccine from the U.S. government.
This follows a $106 million investment into the vaccine made in April,... Read More »
A Phase 1/2 clinical study is getting underway in the United Kingdom for Valneva SE’s vaccine candidate against the SARS-CoV-2 virus responsible for COVID-19.
The French pharmaceutical company said on Wednesday that the VLA2001-201 study is a randomized, double-blind trial to evaluate the... Read More »
The Johns Hopkins Center for Health Security at the Bloomberg School of Public Health has launched a coalition to promote equitable vaccination distribution.
The COVID-19 pandemic has disproportionally affected communities of color in the country. Infection and mortality rates are highest in... Read More »
The U.S. Centers for Disease Control and Prevention (CDC) will award $140 million for COVID-19 vaccine preparedness, the Department of Health and Human Services (HHS) announced.
The CDC will also award almost $87 million for tracking and testing to 64 jurisdictions, including all 50 states and... Read More »
Three entities have initiated real-world testing efforts to determine the most effective measures to address the public transit virus spread reduction.
The U.S. Department of Homeland Security (DHS) Science and Technology Directorate (S&T) has partnered with the New York Metropolitan... Read More »
The U.S. Food and Drug Administration (FDA) has issued the first-ever emergency use authorization (EUA) for an over-the-counter, at-home test for COVID-19, awarding that honor to the rapid Ellume COVID-19 Home Test.
This means anyone at least two years of age or older, whether displaying... Read More »
The U.S. Departments of Health and Human Services (HHS) and Defense (DoD) have partnered with the non-profit Quantum Leap Healthcare Collaborative on a phase 2 clinical trial to screen multiple potential COVID-19 drugs simultaneously.
Unlike many such trials, which focus on a single drug, this... Read More »
A bipartisan bill authorizing a public advocacy campaign to promote COVID-19 vaccine participation and provide science-backed information was introduced in the House this week.
The bill provides necessary funds for the Department of Health and Human Services and the Centers for Disease Control... Read More »
Tel Aviv University (TAU) researchers maintain the coronavirus can be killed efficiently, quickly, and cheaply using ultraviolet (UV) light-emitting diodes (UV-LEDs).
Scientists believe the UV-LED technology would soon be available for private and commercial use, suggesting installation in air... Read More »
Although distribution of the Pfizer COVID-19 vaccine has begun in the United States, Democrats are criticizing reports that the White House failed to pre-order more doses of the vaccine when it had the opportunity and are pressing for more transparent pandemic planning.
News broke last week in... Read More »
In documents released ahead of a vaccine advisory committee meeting on Dec. 17 to discuss the future of Moderna’s COVID-19 vaccine, the U.S. Food and Drug Administration (FDA) determined the two-dose vaccine to be effective and safe for adults.
If approved for emergency use authorization later... Read More »
A COVID-19 vaccine candidate from Sanofi and GSK ran into trouble last week when interim results from a phase 1/2 study showed it to produce little immune response among older adults.
While the candidate showed sufficient results in those aged 18 to 49 years, researchers believe its lack of... Read More »
With the distribution of Pfizer’s COVID-19 vaccine underway in the United States and an emergency use authorization (EUA) expected to follow for Moderna’s vaccine this week, the federal government is preparing through massive logistics and additional purchases.
The government’s Operation... Read More »
A delegation of Maine lawmakers said they are seeking insight from the Department of Health and Human Services (HHS) regarding transparency and communication with state partners on COVID-19 vaccine distribution.
Sens. Susan Collins (R-ME) and Angus King (I-ME) recently joined Reps. Chellie... Read More »
U.S. Reps. John Larson (D-CT) and Joe Courtney (D-CT) recently introduced the Pandemic Supplies Production Act designed to nationalize the production and distribution of supplies deemed essential to fighting the COVID-19 pandemic.
“As we fight through this second surge of COVID-19, we need to... Read More »
The U.S. Food and Drug Administration (FDA) is preparing to quickly authorize the Pfizer Inc.-BioNTech COVID-19 vaccine for emergency use, following an advisory committee's recommendations.
That committee voted 17 to 4 in favor of approval. Once emergency use authorization (EUA) is granted, the... Read More »
Roche has formed a partnership with Moderna to use its Elecsys Anti-SARS-CoV-2 S, or COVID-19, antibody test in Moderna’s mRNA-1273 vaccine research trials.
The Roche tests will provide a quantitative measurement of SARS-CoV-2 antibodies and help to establish a correlation between... Read More »
The National Institutes of Health (NIH) has awarded a $2 million R01 grant to a Virginia Tech research team to develop a single-dose Zika virus vaccine candidate.
"This grant focuses on a new strategy that we developed to produce safe and effective flavivirus vaccines," Jonathan Auguste, an... Read More »
Those in need of a COVID-19 test may no longer need to leave the privacy of their homes, even to gather a prescription for it, with news of authorization granted by the United States Food and Drug Administration to the LabCorp Pixel COVID-19 Test Home Collection Kit.
The first no prescription... Read More »
Top executives of FedEx and UPS assured Congress Thursday their firms have been preparing for months and are ready to transport hundreds of millions of doses of the fledgling COVID-19 vaccines, the first of which is expected to be approved by federal regulators as soon as Thursday.
“We’ve... Read More »
Two Pennsylvania state legislators have introduced a measure necessitating Lyme disease treatment insurance coverage.
State Sens. Michele Brooks (R-50th District) and Doug Mastriano (R-33rd District) circulated a co-sponsorship memo on Dec. 1 seeking support for the bill, which would ensure... Read More »
CARB-X, or Combatting Antibiotic-Resistant Bacteria, recently won an award from the Global Health Technologies Coalition (GHTC) for its progress in expanding the pipeline of innovative products to address antibiotic-resistant bacteria.
The 2020 Innovating for Impact Partnership Award honors an... Read More »
With Americans on the cusp of receiving the first doses of COVID-19 vaccinations, experts from across the public health system on Wednesday recommended specific preparedness actions be taken to ensure that the vaccines will be distributed with the most equity and effectiveness.
“There have... Read More »
According to research published this week in The Lancet journal, the Oxford/AstraZeneca COVID-19 vaccine AZD1222 is safe and effective at preventing the disease, as well as protecting against illness and death.
No severe cases and no hospitalizations were required more than 21 days after the... Read More »
The demand for personal protective equipment (PPE) has continued to increase while supply has been limited by rapid consumption and supply chain disruptions, according to a new study by the Congressional Research Service.
The Congressional Research Service report – called COVID-19 and... Read More »
The World Health Organization (WHO) announced plans this week to release guidance on the systematic screening of tuberculosis (TB), including an updated means of addressing the disease through new approaches, new technologies, and the latest evidence.
“Systematic screening is critical to... Read More »
Organizations gained an easy way to assess the costs of COVID-19 testing plans this week, in the form of a free, online calculator funded and launched by the National Institute of Biomedical Imaging and Bioengineering (NIBIB), a part of the National Institutes of Health (NIH).
Recognizing that... Read More »
The Department of Defense (DoD) has initiated eight Defense Production Act Title III actions as a means of retaining workforce capabilities throughout disruptions caused by the COVID-19 pandemic.
The action would also restore some jobs lost due to the pandemic while sustaining and strengthening... Read More »
